A detailed history of Lockheed Martin Investment Management CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Lockheed Martin Investment Management CO holds 52,120 shares of ABBV stock, worth $8.88 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares
52,120
Previous 44,770 16.42%
Holding current value
$8.88 Million
Previous $8.15 Million 9.65%
% of portfolio
0.52%
Previous 0.57%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$154.79 - $180.76 $1.14 Million - $1.33 Million
7,350 Added 16.42%
52,120 $8.94 Million
Q1 2024

May 13, 2024

SELL
$159.82 - $182.1 $3.34 Million - $3.8 Million
-20,880 Reduced 31.81%
44,770 $8.15 Million
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $2.57 Million - $2.98 Million
19,240 Added 41.46%
65,650 $9.79 Million
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $56,979 - $70,907
-430 Reduced 0.92%
46,410 $6.25 Million
Q1 2023

May 11, 2023

SELL
$144.61 - $166.54 $1.19 Million - $1.38 Million
-8,260 Reduced 14.99%
46,840 $7.46 Million
Q4 2022

Feb 08, 2023

BUY
$138.31 - $165.87 $7.62 Million - $9.14 Million
55,100 New
55,100 $8.9 Million
Q1 2022

May 12, 2022

SELL
$131.98 - $163.75 $10.7 Million - $13.3 Million
-81,150 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $1.27 Million - $1.44 Million
11,920 Added 17.22%
81,150 $8.75 Million
Q2 2021

Aug 06, 2021

SELL
$105.21 - $117.21 $2.09 Million - $2.33 Million
-19,910 Reduced 22.34%
69,230 $7.8 Million
Q1 2021

May 12, 2021

SELL
$102.3 - $112.62 $657,789 - $724,146
-6,430 Reduced 6.73%
89,140 $9.65 Million
Q3 2020

Nov 13, 2020

SELL
$85.91 - $100.83 $71,305 - $83,688
-830 Reduced 0.86%
95,570 $8.37 Million
Q2 2020

Jul 31, 2020

BUY
$73.37 - $98.18 $7.07 Million - $9.46 Million
96,400 New
96,400 $9.46 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Lockheed Martin Investment Management CO Portfolio

Follow Lockheed Martin Investment Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lockheed Martin Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Lockheed Martin Investment Management CO with notifications on news.